(Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
In the media » (Interview) BrainsWay Aims to Treat COVID-Caused Depression by “Jumpstarting” Brain
BrainsWay CEO Christopher von Jako discusses how Deep TMS is used to treat neurological conditions such as depression and obsessive-compulsive disorder exacerbated by the coronavirus (Covid-19) pandemic.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
